CT & MRI company Medic Vision Imaging Solutions Ltd revealed on Tuesday that it has passed the US Food and Drug Administration (FDA) clearance for latest product, iQMR (intelligent Quick MR), to save cost, improve its productivity and boost patients experience and profitability.
The company said the new iterative image reconstruction technology enhances noisy MRI images and significantly increases SNR (signal to noise ratio). The new technology's capabilities enable the use of short MRI protocols and allow increased productivity, fewer repeating scans as well as better patient's experience.
Concurrently, the iQMR supports MRI scanners of all vendors and models, according to the company.
Following the US FDA's clearance, the company will now launch the iQMR at the upcoming ASNR 56th Annual Meeting. Additionally, Prof Lawrence N Tanenbaum, MD, FACR, VP and director of CT, MR & Advanced Imaging at RadNet, will present the results of a clinical study demonstrating the ability to reduce routine brain exam scan time by 30% without adversely affecting image quality using iQMR.
Genentech's Gazyva (obinutuzumab) receives US FDA approval to treat adults with lupus nephritis
AstraZeneca wins US FDA approval for Tezspire in chronic rhinosinusitis with nasal polyps
Antengene reveals ATG-022 clinical data at ESMO 2025
WeightWatchers launches RxFlexFund to expand affordable GLP-1 access for employers and employees
Sebela's MIUDELLA Hormone-Free Copper IUS recognised in TIME's best inventions of 2025
Merck reports positive Phase 3 data for investigational two-drug HIV regimen doravirine/islatravir
60 Degrees reports first patient has tested negative for babesiosis in tafenoquine study
Minovia Therapeutics' MNV-201 receives FDA Orphan Drug Designation for Myelodysplastic Syndrome